Cerebrovascular Complications of COVID-19 on Venovenous Extracorporeal Membrane Oxygenation

Zaaqoq, Akram M. MD, MPH; Griffee, Matthew J. MD; Kelly, Thu-Lan PhD; Fanning, Jonathon P. MD; Heinsar, Silver; Suen, Jacky Y. Ph3; Mariani, Silvia MD; Li Bassi, Gianluigi MD, PhD; Jacobs, Jeffrey P. MD; White, Nicole PhD; Fraser, John F. MD, PhD; Lorusso, Roberto MD, PhD; Peek, Giles J. MD; Cho, Sung-Min DO, MHS; COVID-19 Critical Care Consortium Critical Care Medicine DOI: 10.1097/CCM.0000000000005861

Objective: Evidence of cerebrovascular complications in COVID-19 requiring venovenous extracorporeal membrane oxygenation (ECMO) is limited. Our study aims to characterize the prevalence and risk factors of stroke secondary to COVID-19 in patients on venovenous ECMO.

Previous
Previous

Tracheostomy timing and outcome in critically ill patients with stroke: a meta-analysis and meta-regression

Next
Next

Effect of flow change on brain injury during an experimental model of differential hypoxaemia in cardiogenic shock supported by ECMO